LIDOSTAT Trademark

Trademark Overview


On Tuesday, June 4, 2013, a trademark application was filed for LIDOSTAT with the United States Patent and Trademark Office. The USPTO has given the LIDOSTAT trademark a serial number of 85950608. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, October 9, 2024. This trademark is owned by Clinical Therapeutic Solutions. The LIDOSTAT trademark is filed in the Pharmaceutical Products category with the following description:

topical lidocaine cream for podiatric pain use
lidostat

General Information


Serial Number85950608
Word MarkLIDOSTAT
Filing DateTuesday, June 4, 2013
Status800 - REGISTERED AND RENEWED
Status DateWednesday, October 9, 2024
Registration Number4573484
Registration DateTuesday, July 22, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2013

Trademark Statements


Goods and Servicestopical lidocaine cream for podiatric pain use
Pseudo MarkLIDO STAT

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 13, 2013
Primary Code005
First Use Anywhere DateFriday, January 10, 2014
First Use In Commerce DateFriday, January 10, 2014

Trademark Owner History


Party NameBAKOTIC PATHOLOGY ASSOCIATES, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressALPHARETTA, GA 30005

Party NameClinical Therapeutic Solutions
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWall, NJ 07719

Party NameClinical Therapeutic Solutions
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWall, NJ 07719

Party NameClinical Therapeutic Solutions
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWall, NJ 07719

Trademark Events


Event DateEvent Description
Tuesday, December 24, 2013NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 6, 2014TEAS STATEMENT OF USE RECEIVED
Friday, June 7, 2013NEW APPLICATION ENTERED
Thursday, June 13, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 14, 2013NOTICE OF PSEUDO MARK MAILED
Tuesday, September 10, 2013ASSIGNED TO EXAMINER
Thursday, September 12, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2013NOTICE OF PUBLICATION
Tuesday, October 29, 2013PUBLISHED FOR OPPOSITION
Thursday, February 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 20, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 6, 2014USE AMENDMENT FILED
Wednesday, June 4, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, June 2, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 13, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 17, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, July 22, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, January 27, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, February 3, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, July 22, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 16, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 16, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, September 16, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, July 22, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, July 19, 2024TEAS SECTION 8 & 9 RECEIVED
Wednesday, October 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 9, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, October 9, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, October 9, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, July 13, 2020TEAS SECTION 8 & 15 RECEIVED